Fjarde Ap-fonden’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $45.7M | Buy |
1,898,971
+457,700
| +32% | +$12M | 0.22% | 89 |
|
|
2026
Q1 | $40.5M | Buy |
1,441,271
+519,500
| +56% | +$13.8M | 0.22% | 91 |
|
|
2025
Q4 | $23M | Sell |
921,771
-92,200
| -9% | -$2.33M | 0.19% | 109 |
|
|
2025
Q3 | $25.8M | Buy |
1,013,971
+12,700
| +1% | +$313K | 0.22% | 93 |
|
|
2025
Q2 | $24.3M | Buy |
1,001,271
+207,000
| +26% | +$4.83M | 0.22% | 98 |
|
|
2025
Q1 | $20.1M | Sell |
794,271
-549,500
| -41% | -$14.4M | 0.24% | 90 |
|
|
2024
Q4 | $35.6M | Sell |
1,343,771
-16,000
| -1% | -$434K | 0.36% | 45 |
|
|
2024
Q3 | $39.4M | Buy |
+1,359,771
| New | +$39.7M | 0.4% | 44 |
|
|
2024
Q1 | $44.3M | Buy |
1,595,571
+29,700
| +2% | +$824K | 0.49% | 37 |
|
|
2023
Q4 | $45.1M | Sell |
1,565,871
-101,743
| -6% | -$3.08M | 0.56% | 31 |
|
|
2023
Q3 | $55.3M | Sell |
1,667,614
-33,900
| -2% | -$1.2M | 0.73% | 24 |
|
|
2023
Q2 | $62.4M | Buy |
1,701,514
+29,500
| +2% | +$1.15M | 0.77% | 25 |
|
|
2023
Q1 | $68.2M | Sell |
1,672,014
-24,300
| -1% | -$1.05M | 0.92% | 21 |
|
|
2022
Q4 | $86.9M | Sell |
1,696,314
-107,664
| -6% | -$5.16M | 1.24% | 10 |
|
|
2022
Q3 | $94.6M | Hold |
1,803,978
| – | – | 1.19% | 10 |
|
|
2022
Q2 | $94.6M | Buy |
1,803,978
+392,200
| +28% | +$20M | 1.19% | 10 |
|
|
2022
Q1 | $73.1M | Sell |
1,411,778
-83,699
| -6% | -$4.34M | 0.72% | 20 |
|
|
2021
Q4 | $88.3M | Sell |
1,495,477
-92,934
| -6% | -$4.6M | 0.78% | 18 |
|
|
2021
Q3 | $68.3M | Sell |
1,588,411
-23,200
| -1% | -$1.03M | 0.63% | 25 |
|
|
2021
Q2 | $63.1M | Sell |
1,611,611
-85,900
| -5% | -$3.34M | 0.58% | 31 |
|
|
2021
Q1 | $61.5M | Buy |
1,697,511
+28,200
| +2% | +$1M | 0.56% | 30 |
|
|
2020
Q4 | $61.4M | Sell |
1,669,311
-107,639
| -6% | -$3.95M | 0.58% | 29 |
|
|
2020
Q3 | $61.9M | Buy |
1,776,950
+62,291
| +4% | +$2.18M | 0.67% | 29 |
|
|
2020
Q2 | $53.2M | Buy |
1,714,659
+86,217
| +5% | +$2.93M | 0.67% | 29 |
|
|
2020
Q1 | $50.4M | Sell |
1,628,442
-71,461
| -4% | -$2.43M | 0.81% | 19 |
|
|
2019
Q4 | $63.2M | Sell |
1,699,903
-44,162
| -3% | -$1.57M | 0.78% | 25 |
|
|
2019
Q3 | $59.5M | Sell |
1,744,065
-18,713
| -1% | -$680K | 0.77% | 27 |
|
|
2019
Q2 | $72.5M | Sell |
1,762,778
-137,126
| -7% | -$5.45M | 0.93% | 17 |
|
|
2019
Q1 | $76.6M | Buy |
1,899,904
+379,642
| +25% | +$15.2M | 0.96% | 13 |
|
|
2018
Q4 | $63M | Sell |
1,520,262
-113,094
| -7% | -$4.69M | 1.09% | 11 |
|
|
2018
Q3 | $68.3M | Sell |
1,633,356
-108,401
| -6% | -$4.17M | 1.01% | 12 |
|
|
2018
Q2 | $60M | Sell |
1,741,757
-52,246
| -3% | -$1.79M | 0.91% | 18 |
|
|
2018
Q1 | $60.4M | Buy |
1,794,003
+17,084
| +1% | +$587K | 0.92% | 17 |
|
|
2017
Q4 | $61.1M | Buy |
1,776,919
+272,862
| +18% | +$9.3M | 0.93% | 18 |
|
|
2017
Q3 | $50.9M | Buy |
1,504,057
+51,381
| +4% | +$1.65M | 0.97% | 15 |
|
|
2017
Q2 | $46.3M | Buy |
1,452,676
+167,857
| +13% | +$5.29M | 0.93% | 16 |
|
|
2017
Q1 | $41.7M | Sell |
1,284,819
-82,241
| -6% | -$2.59M | 1% | 15 |
|
|
2016
Q4 | $42.1M | Sell |
1,367,060
-139,549
| -9% | -$4.26M | 0.99% | 17 |
|
|
2016
Q3 | $48.4M | Buy |
1,506,609
+8,264
| +0.6% | +$276K | 1.06% | 15 |
|
|
2016
Q2 | $50.1M | Buy |
1,498,345
+18,215
| +1% | +$581K | 1.16% | 14 |
|
|
2016
Q1 | $41.6M | Buy |
1,480,130
+189,012
| +15% | +$5.4M | 0.96% | 16 |
|
|
2015
Q4 | $39.5M | Buy |
1,291,118
+6,704
| +0.5% | +$211K | 1.04% | 14 |
|
|
2015
Q3 | $38.3M | Sell |
1,284,414
-81,707
| -6% | -$2.62M | 1.07% | 11 |
|
|
2015
Q2 | $43.5M | Sell |
1,366,121
-137,014
| -9% | -$4.47M | 1.05% | 10 |
|
|
2015
Q1 | $49.6M | Sell |
1,503,135
-89,441
| -6% | -$2.84M | 1.14% | 9 |
|
|
2014
Q4 | $47.1M | Sell |
1,592,576
-119,363
| -7% | -$3.42M | 1.02% | 11 |
|
|
2014
Q3 | $48M | Sell |
1,711,939
-141,560
| -8% | -$3.97M | 1.03% | 12 |
|
|
2014
Q2 | $52.2M | Sell |
1,853,499
-130,864
| -7% | -$3.73M | 1.04% | 12 |
|
|
2014
Q1 | $60.5M | Buy |
1,984,363
+29,009
| +1% | +$865K | 1.2% | 11 |
|
|
2013
Q4 | $56.8M | Sell |
1,955,354
-88,253
| -4% | -$2.57M | 1.19% | 11 |
|
|
2013
Q3 | $55.7M | Sell |
2,043,607
-177,909
| -8% | -$4.84M | 1.2% | 12 |
|
|
2013
Q2 | $59M | Buy |
+2,221,516
| New | +$61.4M | 1.23% | 13 |
|
Other funds holding PFE
AIM
SLAM
CWP
Fjarde Ap-fonden's PFE Position: Q2 2026 in Review
Fjarde Ap-fonden increased its Pfizer (PFE) stake by 32% in Q2 2026, buying an estimated $12M and bringing the position to 1,898,971 shares worth $45.7M. The position accounts for 0.22% of the portfolio, ranked #89.
Fjarde Ap-fonden first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $94.6M in Q3 2022. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fjarde Ap-fonden held 1,898,971 shares of Pfizer worth $45.7M as of Q2 2026.
- Fjarde Ap-fonden bought 457,700 Pfizer shares in Q2 2026, an estimated $12M.
- Pfizer made up 0.22% of Fjarde Ap-fonden's portfolio in Q2 2026, its #89 holding.
- Fjarde Ap-fonden first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Fjarde Ap-fonden's Pfizer position peaked at $94.6M in Q3 2022.
- 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fjarde Ap-fonden's 13F filing for Q2 2026, filed 29 Jul 2026.